No worries, I had the impression that you/your company had previously done work for Medcan - dont really care about who is saying what, it could go either way, I dont know. I would welcome a decision either way.
Its looking like a tough year ahead globally so expect challenges along the way. 2024/25 is hopefully looking better for everyone.
- Forums
- ASX - By Stock
- CGB
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-25
-
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online